A diverse immune repertoire is considered a hallmark of good health. However, other things 8 being equal, current methods for measuring repertoire diversity cannot distinguish between a 9 repertoire composed of similar sequences (clonotypes, clones) and a repertoire composed of 10 different ones, even though the latter is intuitively more diverse. Here we describe a framework 11 for incorporating similarity into diversity measures, and measure immunological diversity with 12 similarity on 391 large-scale antibody and T-cell receptor (TCR) repertoires. We find that while 13 repertoires often contain millions of unique sequences, diversity with similarity suggests a 14 landscape defined by at most a few thousand unrelated CDR3 binding targets. Naïve/IgM 15 repertoires have more unique sequences than memory/IgG, but with similarity, memory/IgG 16 repertoires are more diverse. Diversity with similarity is sensitive to vaccination, infection, and 17 aging, and unlike diversity without similarity is robust to sampling error. Finally, with similarity, 18 repertoires from different people overlap significantly, suggesting a definable ceiling for the 19 functional diversity of humanity. Similarity redefines diversity in complex systems. 20
Introduction express many millions of unique recombined antibody and TCR genes as part of millions of 23 clonal lineages, more unique sequence than in the entire germline genome (Jiang et al., 2013) . 24
At the sequence level, the repertoires of any two people overlap by only a fraction of a percent, 25 indicating still higher diversity in the population (Arnaout et al., 2011; Robins et al., 2010 ). Yet 26 repertoires are formed from V, D, and J gene segments that almost all people share and that 27 are expressed at similar frequencies across individuals targets (de Bourcy et al., 2017; DeWitt 28 et al., 2016) , and repertoires are shaped by similar antigenic exposures and a consequent need 29 to recognize and bind similar. Squaring the diversity that is seen with the similarity that must 30 exist is a major goal in immunology. 31
This goal has relevance for disease stratification and clinical management across a range of 32 conditions. B-and T-cell diversity fall with age, as specific exposures expand a few select 33 lineages at the expense of others (Messaoudi et al., 2004) . Chronic infection appears to have a 34 similar effect, impairing vaccination (Jiang et al., 2013) . Low B-cell diversity is associated with 35 physiological frailty, a syndrome seen alongside conditions that are traditionally considered to 36 be unrelated to adaptive immunity (e.g., atherosclerotic cardiovascular disease), independent of 37 chronological age (Gibson et al., 2009 ). In cancer, a rise in sequence-level T-cell diversity is 38 thought to predict a successful response to immune-checkpoint inhibitors, drugs that make 39 tumors more visible to the immune system (Hopkins et al., 2018) . 40
Mathematically, the key innovation of diversity-with-similarity relative to raw diversity is inclusion 84 of a similarity matrix whose entries quantify how similar each pair of species (sequences, 85 clonotypes, etc.) is. Constructing the similarity matrix necessitates a choice of similarity 86 measure. (Note the difference between similarity measures and diversity measures: a similarity 87 measure is used to build the similarity matrix, which then is used to calculate diversity 88 measures.) The choice of similarity measure depends on the biological feature(s) of interest. For 89 example to study somatic hypermutation, one might use the Hamming distance. Just as 90 different weightings provide complementary information about rare vs. frequent species-for 91 example, the number of new thymic emigrants (species richness; 0 D or ∅ D s ) vs. large leukemic 92 clones (Berger-Parker index; ∞ D)-different similarity measures are expected to reveal different 93 systems-level features of repertoires' sequence-level configuration. Also as with raw diversity 94 measures, expressing results for the new diversity-with-similarity measures as effective 95 numbers, also known as number equivalents, (Macarthur, 1965; Hill, 1973; Jost, 2007; Marion 96 et al., 2015) , as opposed to as bits or nats (for 1 D s ) or as various fractions (for >1 D s ), makes it 97 possible to compare them to each other, regardless of weighting or similarity measure, on a 98 single intuitive scale (Box 1). 99
Similarity measure. We were interested in the single most fundamental mechanistic feature of 100 antibodies and TCRs: binding to specific targets (Fig. 1) . Therefore for our similarity measure, 101 we used a proxy for binding affinity that follows from the empirically observed changes in 102 dissociation constant (K d ) associated with amino-acid substitution in antibody and TCR CDRs 103 (Jankauskaite et al., 2018) . We found that on average, a single amino-acid substitution at an 104 antibody-antigen or TCR-peptide binding surface lowers affinity by 4-5 fold (geometric mean), 105
Robustness. Sampling error-the "missing-species" problem (Bunge and Fitzpatrick, 152 1993 (Bunge and Fitzpatrick, 1993) )-is known to be a major potential confounder when 153 measuring raw diversity, necessitating large (e.g.) blood volumes and/or post-hoc statistical 154 correction for measurements on the sample to reflect repertoire diversity in the individual as a 155 whole (Kaplinsky and Arnaout, 2016) . A practical feature of functional similarity is that the 156 values are smaller than those of raw diversity (reflecting clustering of similar sequences; Fig. 1-157 2). The effective coverage is therefore greater, meaning that less information about the 158 functional diversity of an individual's overall repertoire is lost upon sampling than is the case for 159 raw diversity. This observation suggested that functional diversity is more robust to sampling 160 error, possibly even making it accurate enough to use without statistical correction, and thus 161 useful for the sample sizes typically available for sequencing (10,000-1 million cells). 162
To test this possibility, we systematically downsampled from a representative TCRβ repertoire 163 and two representative IgH (IgG) repertoires, one prepared from mRNA and one from genomic 164 DNA, each with ~10 6 unique sequences, and compared raw vs. functional diversity on the 165 subsamples to those of the full sample ( Fig. 3 ). (We wished to consider possibility of lower 166 diversity from mRNA than DNA, since transcriptionally less active cells may be less likely to be 167 sampled.) For TCRβ, we found that functional species richness saturated at a sample size of 168 ~30,000 sequences and functional entropy at ~10,000 sequences (Fig. 3b , first and third 169 columns). Functional diversity for higher frequency weightings (q) saturated with even fewer 170 sequences. For IgH from mRNA, functional species richness did not saturate but did plateau, 171 with a final increase of ≤2 percent per order of magnitude. Assuming that each unique sequence 172 corresponds to a cell and 10 10 B cells in the body, this final measured rate of increase means 173 that the individual's total functional species richness is no more than 50 percent higher than the 174 value measured on the sample (Fig. 3 , middle row). This is the maximum expected sampling 175 error. For IgH from DNA, functional species richness had begun to plateau at the full sample 176 size, resulting in the value for the individual being no more than three times as much as in the 177 sample (maximum three-fold error). Meanwhile, functional entropy saturated at 30,000 cells for 178
IgH from mRNA and 300,000 cells for IgH from DNA. This behavior was in marked contrast to 179 that of raw diversity, which did not saturate or plateau for species richness (Fig. 3, white any IgH or TCR repertoire. We reasoned that a "meta-repertoire" comprising sequences drawn 184 uniformly (i.e., without regard to frequency) from many individuals will be more diverse, by any 185 measure, than any single repertoire (which will have fewer sequences, and in which the same 186 sequence may appear multiple times). Downsampling from a meta-repertoire therefore provides 187 an upper bound or worst-case scenario for the sampling requirements for any single repertoire. 188
To build meta-repertoires, we pooled and then uniqued CDR3s from 114 different IgH 189 repertoires from 79 individuals including Americans of African, European, and Hispanic descent 190 (Bild et al., 2002; DeWitt et al., 2016; Vollmers et al., 2013) to build an IgH meta-repertoire of 191 roughly 36 million unique sequences-as many as or more than ever observed or currently 192 estimated to be in a typical individual-and similarly for CDR3s from TCRβ repertoires from 69 193 healthy individuals (of mostly European but some Asian descent) (Emerson et al., 2017) to build 194 a TCRβ meta-repertoire of 10 million unique sequences, and downsampled from each of these 195 meta-repertoires as above ( Fig. 3 , large circles). We found that functional diversity plateaued for 196 all q, saturated for q≥1 and reflected overall diversity to within a few percent from sample sizes 197 of 50,000 for TCRβ and IgH RNA and 100,000 for IgH DNA for q=0, and 30,000 for TCRβ and 198
IgH RNA and 300,000 for IgH DNA for q≥1 ( Fig. 3 , large colored circles). Together, these results 199 confirmed that functional diversity measured on samples is an accurate measure of overall 200 functional diversity in the individual, at conventional sample sizes. 201
Raw and functional diversity. We measured raw and functional diversity on 141 healthy 202 human subjects ( Fig. 4 ). For IgH, we found a (geometric) mean functional species richness 203 ( D s ) of 677 (range, 487-916) from mRNA and 2,205 (range, 2,042-2,485) from DNA, 204 suggesting that on average, the human antibody repertoire is capable of recognizing the 205 equivalent of no more than a few thousand unique non-overlapping heavy-chain CDR3 binding 206 targets. (As above, lower diversity from mRNA was not unexpected, since inactive cells, which 207 produce less IgH mRNA than active cells, may be underrepresented.) For TCRβ the mean 208 functional diversity was 140 targets (range, 115-167). Functional diversity can be thought of as 209 clustering similar sequences together, although functional clusters can overlap and sequences 210 can belong to multiple clusters. An indication of the average size of these clusters can be 211 obtained by taking the ratio of raw to functional diversity measures. For species richness, we 212 found that IgH typically had hundreds of sequences per cluster, while TCRβ had thousands. 213
Thus by both functional diversity and average functional-cluster size, IgH CDR3 repertoires are repertoire types. Thus, functional diversity generally complements raw diversity, adding 217 information not captured by raw diversity alone. 218 Naïve vs. memory B cells. We next sought to investigate what this information might add to our 219 understanding of adaptive immunity. We began with two widely studied B-cell subsets, naïve 220 (IgM) and memory cells (predominantly IgG). Previous studies have shown that naïve 221 repertoires have higher raw diversity than memory repertoires (DeWitt et al., 2016) . This is at 222 least superficially consistent with the fact that only a subset of naïve cells are selected to enter 223 into the memory compartment. However, in a functional sense there is a case to be made that 224 memory/IgG repertoires should be more diverse, since somatic hypermutation differentiates 225 memory cells from naïve cells, and indeed from each other. Using well-characterized publicly 226 available repertoires from DNA from three healthy human subjects, we confirmed that by raw 227 species richness, naïve (CD27 -IgM + ) B-cell repertoires are ~10 times as diverse as memory 228 (CD27 + IgM -) repertoires (DeWitt et al., 2016) ( Fig. 5a-b ). Yet by functional species richness, we 229 found that memory repertoires were at least as diverse as naïve (Figs. 5a-b). Comparing raw 230 and functional diversity for 34 IgM and 32 IgG repertoires from mRNA (repertoires with less than 231 100,000 total sequences were discarded) from 28 additional healthy individuals from a separate 232 dataset showed a similar pattern as for the three DNA repertoires: in all but a few outliers, IgM 233 had higher raw diversity but IgG had higher functional diversity ( Fig. 5c-d ). For raw diversity, the 234 IgM:IgG ratio rose from ~3:1 at q=0 to peak at 10:1 around q=1, due to a large fraction of rare 235 IgG sequences ( Fig. 5d ). This effect was more pronounced for naïve:memory ( Fig. 5b ). For 236 functional diversity, the absence of a peak in the IgM:IgG ratio suggests that these many rare 237 sequences must nonetheless be similar to others in the repertoire, possibly because they are 238 members of clones ( Fig. 5b,d ). 239
Cytomegalovirus (CMV) exposure. CMV is a herpesvirus to which half of the adult population 240 has been exposed and results in life-threatening opportunistic infections in newborns, transplant 241 recipients, and immunocompromised individuals (Emery, 2001) . In most healthy individuals, it 242 causes a chronic infection marked by clonal expansion of both B cells and T cells and a 243 consequent fall in raw diversity, an effect also seen during aging (see below) (de Bourcy et al., 244 2017; Qi et al., 2014). We measured raw and functional TCRβ CDR3 diversity for 120 245 individuals: 69 CMV-seronegative and 51 CMV-seropositive subjects aged 19-35 (Emerson et 246 al., 2017) , the narrow age range helping control for any age-related effects. There was a clear 247 trend toward lower diversity in the CMV-seropositive group relative to the CMV-seronegative 248 group by both raw and functional diversity, for all weighting parameters ( Fig. 6a ). Combining raw 249 with functional diversity facilitated identification of two subgroups among the subjects with 250 known CMV status: subjects with a high raw Berger-Parker Index ( ∞ D) were almost always 251 CMV-seronegative ( Fig. 6b ), whereas subjects with low functional Berger-Parker Index ( ∞ D s ) 252
were almost always CMV-seropositive ( Fig. 6c ). The reverse-low ∞ D or high ∞ D s -did not 253 distinguish between the groups. Using both measures gave a better indication of CMV status 254 than did either one alone (Fig. 6d ). The conclusion is that CMV is unlikely in the absence of 255 large clones/expanded lineages, as has been reported, but is likely only if the large 256 clones/expanded lineages that are present exhibit high similarity to other clones/lineages in the 257 repertoire, or else are indeed very large ( Fig. 6e ). Again, the addition of functional diversity 258 offers insight that raw diversity alone does not. 259
Flu vaccination. Vaccination with a seasonal trivalent influenza vaccine (TIV) triggers clonal 260 expansion in B cells. Previous work on five vaccinees showed likely flu-specific memory IgG 261 lineages emerging by day 7 post-vaccination (Vollmers et al., 2013) . We found that combining 262 raw and functional diversity reveals a signature of clonal expansion and selection without the 263 need for lineage tracking (Fig. 7 ). We measured raw and functional diversity for IgM and IgG at 264 day 0 (pre-administration) and day 7 from all 14 vaccinees in Vollmers' dataset. We found that 265 for most subjects, for IgG, raw species richness rose from day 0 to day 7 while functional 266 species richness fell ( Fig. 7a-b ). This means that even as the number of sequences increased, 267 many of the new sequences were similar to each other (or to existing sequences), and they 268 tended to replace different-looking sequences. Meanwhile, there was no obvious pattern in IgM 269 ( Fig. 7c ). Together, these results are what we would expect from clonal expansion and selection 270 in a memory response, and thus represent a repertoire-level signature of these phenomena. 271
Interestingly, in most cases, raw and functional entropy both fell ( Fig. 7a -b, right panels). This 272 suggests that most of the new sequences at day 7 were rare, while at the same time a subset of 273 sequences and functional clusters grew. Thus overall, the addition of functional diversity reveals 274 a key feature of clonal dynamics, which is not evident from raw diversity alone. 275
Aging. To explore the effect of age, we measured raw and functional diversity for TCRβ CDR3 276 repertoires from 41 healthy individuals aged 6-90 years old (Britanova et al., 2014) ( Fig. 8 ). We 277 found that raw diversity falls with age regardless of weighting parameter; a fall in raw species 278 richness had been reported previously (Britanova et al., 2014) . Functional diversity also fell, 279 regardless of weighting parameter. However, for species richness, four septuagenarians bucked of other individuals of similar age, their functional species richness was similar to that of 282 children. Only one of these four had a high likelihood of being CMV-negative; the probability that 283 all four were CMV-negative was low. We therefore consider CMV unlikely as an explanation for 284 their high functional species richness. Unlike their peers, these four appear to have retained 285 functional diversity among their rarest sequences. (The alternative hypothesis is that these four 286 saw a rise in functional species richness from a lower level earlier in life, but we think this 287 unlikely given the overall downward trend across individuals.) We considered but excluded 288 PCR/sequencing artifacts as the cause, as we expected such artifacts would have led to larger 289 raw species richness, which was not observed. Thus, functional diversity identified for further 290 study individuals who were unremarkable by raw diversity alone. 291
Discussion 292
Diversity both affects function, and reflects it. In the adaptive immune system, the defining 293 tradeoff is breadth vs. depth: a repertoire must be sufficiently diverse to contain sequences that 294 can recognize a given target and lead to useful clones, but not so diverse that cells that express 295 such sequences are too rare to find the target on biologically relevant timescales (Schober et 296 al., 2018; Zarnitsyna et al., 2013) . To monitor immunological diversity, either diagnostically or 297 therapeutically, we must be able to measure it, and to measure it, we must define it. It is 298 increasingly recognized that a reasonable definition of immunological diversity must account for 299 differences in species frequency. Here we argue such a definition must also account for 300 species' pairwise similarity, and show that binding similarity, which leads to what we call 301 functional diversity, provides useful insight into repertoire function. 302
Pairwise similarity can be seen as governed by a tunable parameter that helps define the 303 similarity matrix, analogous to how q is a tunable parameter that governs the effect of 304 differences in frequency (Chao et al.) . In our study, the similarity matrix is defined by the 305 average single amino-acid change in K d , an average based on over 1,300 independent 306 measurements, and the assumption of multiplicative independence. This source data is not 307 systematic, but to our knowledge is the best available. While our study is to our knowledge the 308 first of its kind, it follows a long tradition of attempts to estimate the number of binding targets 309 that can be recognized by the adaptive immune system immunization (Bachmann et al., 1994; 310 Obar et al., 2008) . In these past studies, typically a sample of B or T cells was diluted until 311 binding to/protection from a given target was abolished, using whatever thresholds the same as the one under study. Such studies gave functional diversities of 100 to 100,000 targets 316 for various T-cell populations and for B cells after antigen exposure, a wide range (Bachmann et 317 al., 1994; Obar et al., 2008) . The width of this range may reflect real differences in the 318 frequencies of cells that are specific for different targets, or variability in stringency or 319 experimental setup. Interestingly, this "how-many-can-fit" logic seems not to have been used 320 when testing so-called natural antibodies, which bind many targets at low affinity (Frank, 2002; 321 Holodick et al., 2017; Notkins, 2004) . For example, when one in five natural antibodies were 322 found to bind insulin (Chen et al., 1998) , this was not taken to mean that the repertoire could 323 recognize only five targets, because of presumed overlapping specificity of these antibodies for 324 other targets. Meanwhile, theoretical studies have suggested a need for ≤10,000 binding and Arnaout, 2016). On average, these raw species richnesses mean that each of 100-100,000 332 putative binding targets can be bound by 100-100,000 unique CDR3s (10 7 /10 5 to 10 7 /10 2 ). From 333 a medical perspective, such redundancy is good for treatment, because it supports the 334 prevailing view that there are many ways to design an antibody-or TCR-based drug that will 335 recognize a given target, but potentially a complicating factor for attempts to diagnose specific 336 diseases based on repertoire sequence, because it suggests that signatures of exposure to a 337 given target may be quite variable. 338
One of our key findings is that functional diversity is much lower than raw diversity: repertoires 339 contain only a few hundred functional clusters for TCRβ CDR3s and at most a few thousand for 340
IgH. The fact that functional diversity is based on K d s suggests that functional diversity should 341 correlate with the number of structurally unique, non-overlapping target clusters that CDR3s can 342 recognize ( Fig. 1 ). Yet our measurements of functional species richness lie at the low end of the 343 range of prior estimates. We propose two explanations. First, our measurements are limited to 344 CDR3s; variability in the rest of the antibody or TCR protein must add to the total number of 345 potential binding targets. This possibility is testable by extending our method to more or indeed all of the antibody or TCR sequence. Second, functional diversity may be providing a less 347 detailed description of shape space than limiting-dilution studies: i.e., functional diversity may be 348 a coarse graining of the target-binding landscape (Fairlie-Clarke et al., 2009; Smith et al., 1997) 349 ( Fig. 9) . A pair of sequences may be similar enough to lie near each other in shape space, but 350 only one may bind a given target above a threshold level of specificity in a binding study. In 351 short, binding studies may be counting peaks while functional diversity is counting mountains. If 352 true, our results suggest that the landscape of TCRβ CDR3 binding is more clustered than that 353
of IgH, such that there are on average several times as many functional IgH clusters as TCRβ. 354
This prediction is testable, at least in principle, through large-scale systematic binding assays to 355 measure K d , or by measuring binding as a binary outcome at multiple stringency thresholds. 356
Both explanations may contribute. To our knowledge ours is the first attempt a quantitative 357 summary of this landscape using data from large-scale binding studies and high-throughput 358 repertoire sequencing. 359
Why is CDR3 functional diversity higher for IgH than for TCRβ? We hypothesize that it is for the 360 same three reasons that there is more sequence diversity for IgH than TCRβ. First, humans 361 have 23 D H gene segments vs. only 2 D β segments, and D is the largest germline contributor to 362 CDR3. V and J segments tend to directly contribute little more than the canonical starts and 363 ends of CDR3s, and besides there are similar numbers of V-J combinations in IgH as TCRβ 364 (49×6=294 and 48×13=624, respectively). Second is somatic hypermutation, which diversifies 365
IgH but not TCRβ. And third, IgH CDR3s are longer than TCRβ CDR3s, allowing for a larger 366 number of possible sequences. Further analysis will be needed to test these hypotheses. 367
We have shown how functional diversity complements raw diversity to offer insight into the 368 difference between naïve and memory repertoires, to aid in identification of disease states, and 369 to illustrate clonal selection and other repertoire dynamics. We hope these examples will sequences, which ran into the millions in most of the repertoires we investigated, and the much 375
smaller numbers of what we call functional clusters (the effective numbers of functional 376 diversity). The result is a "functional degeneracy" among sequences that are organized into 377 functional clusters. Characterizing these clusters is an interesting topic for future work. 378
Functional similarity also offers a new perspective on similarities and differences between 379 people. To show that functional diversity is robust to sampling, we generated "meta-repertoires" 380 by pooling sequences from scores and in some cases over a hundred people, including people 381 from different ethnic backgrounds. Surprisingly, and somewhat unexpectedly given the low 382 sequence overlap between pairs of individuals, the functional diversity of these meta-repertoires 383 never exceeded the functional diversity of any given repertoire by more than a few fold; 384 moreover, the functional diversity trended toward saturating in samples of just a million 385 sequences (Fig. 3) . Together, these findings predict that any two individuals share a majority of 386 their functional clusters, in stark contrast to the vanishingly small fraction of sequences they 387 share. Further, these findings suggest that the functional diversity of the entire population is only 388 a few hundred clusters for TCRβ CDR3s and a few thousand for IgH, and imply that these 389 clusters can be sampled exhaustively by sequencing fewer than 20 individuals. It will be 390 fascinating to test this finding with additional ethnically and geographically diverse populations, 391 to further examine our prediction that, contrary to conventional wisdom, the functional limits of 392 the adaptive immune system are in a practical sense both finite and within reach. 393
The focus of this study was binding similarity, but we expect that the utility of the diversity-with-394 similarity framework will extend to other facets of immunology (e.g., somatic hypermutation) and 395 to other fields, most readily metagenomics, sociology, oncology, and cellular cartography 396 To develop a model for our similarity measure, s, we downloaded SKEMPI 2.0, which is to our acid substitution on protein-protein binding (Jankauskaite et al., 2018) . Each entry includes a the dissociation constant (K d ) of each member of the pair (referred to in the database and Fig.  445 2a as "wild type" and "mutant"). We extracted entries for all single amino-acid substitutions for 446 which K d for both wild type and mutant were recorded, and considered only entries that involved 447 binding between antibody and antigen (n=797) or TCR and peptide/MHC (n=531; total 448 n=1,328). Although amino-acid substitutions anywhere in a protein may affect binding, 449 substitutions at the core of the binding interface are more likely to affect binding than 450 substitutions elsewhere (Levy, 2010) . Therefore we split the data into core (n=584) and non-451 core (n=744) groups and analyzed the effect of substitution binding, measured as 452 |log 10 (K dmut /K dwt )|, separately for each group. 453
As expected, the probability distributions for the two groups differed substantially from each 454 other (Mann-Whitney U p-value 2.0x10 -33 ). Substitution of a core residue had a 13-fold 455 (geometric) mean effect on binding, consistent with prior reports (Whittaker et al., 2001) , while 456 substitution of a non-core residue had a 4-fold effect. Both probability distributions were long-457 tailed, and were reasonably well described by exponential probability-density functions (i.e., of 458 the form ke -kx ). We confirmed that the distributions for antibody-antigen core residues (n=352) 459 and TCR-peptide/MHC core residues (n=232) were similar to each other, that the distributions 460 for antibody-antigen non-core residues (n=445) and TCR-peptide/MHC non-core residues 461 (n=299) were also similar to each other, that within each of the antibody-antigen and TCR-462 peptide/MHC subgroups the distributions for core and non-core residues were different, and that 463 these results held separately for human and non-human (nearly all of which were mouse) 464 sequences (using the Structural Antibody Database (Dunbar et al., 2014) found that to a good approximation, a constant fraction 0.15±0.05 of CDR3 amino acids consist 470 of core residues, with no obvious difference between chain types. To estimate the effect of a a few having effects of many orders of magnitude ( Fig. 2a ). There were small spikes in the tail 475 for substitutions with ≳60-fold effects, i.e. |log 10 (K dmut /K dwt )|≳1.8. A review of sources cited by 476 SKEMPI suggested that these spikes likely reflect ascertainment bias: selective experimentation 477 on amino acids with unusually strong effects (e.g. Pons et al., 1999; Taylor et al., 1998) . To 478 counteract such bias, we therefore built a high-confidence dataset using 1.8 as the cutoff. 479
Ascertainment bias in two-and three-amino-acid substitutions is expected to follow the square 480 and cube of the bias in single-amino-acid substitutions, respectively, precluding rigorous 481 conclusions from being drawn from independence testing. However, comparison with those 482 groups was broadly consistent with either multiplicative (s=c m , where s=similarity; c=the cost of 483 binding, i.e., 1/(fold effect); m=edit distance) or additive (s=c/m for m≥1) independence. 484
Because additive effects result in higher pairwise similarities and therefore smaller repertoire 485 diversities than multiplicative effects, the multiplicative-independence model is more 486 conservative for studying the effects of similarity on diversity. We therefore chose the 487 multiplicative model for further analysis. 488
To determine the similarity between two CDR3s with edit distance m, we sampled 489 independently from the high-confidence dataset m times, and multiplied the costs together. We 490 confirmed that on average, the results of this stochastic sampling were the same as 491 deterministic calculation of s=c m with c≈0.55. We performed sensitivity analysis based on lower-492 confidence cutoffs (down to c=0.48) and alternative assumptions (up to c=0.60). This resulted in 493 somewhat higher or lower diversity values, but qualitative patterns were robust to these 494 perturbations.
made a minor change to the notation, from q D Z to q D s . 507
Use of this framework raised two issues that we addressed. First, its q=0 measure, 0 D s , 508 depends on frequency albeit to a very small extent, unlike the Hill framework's q=0 measure, 0 D, 509 which is species richness (and is independent of frequency). Therefore, as a more direct 510 comparison to species richness, we calculated 0 D s both with frequency information and without 511 it (i.e., setting the frequencies of each of the n species to 1/n). We refer to the latter as ∅ D s ("D-512 null"). Second, it has been shown that this framework can result in unreasonably low diversity 513 values when most of the off-diagonal entries of the similarity matrix are far from zero, resulting 514 in an insensitivity to q (Botta-Dukát, 2018; Chiu and Chao, 2014) . We expected most of our off 515 diagonals to be close to zero, since our similarity measures directly or indirectly involve 516 exponential decay, which generates small values, but confirmed that most of the off diagonals in 517 our similarity matrices were indeed close to zero by plotting histograms. Consequently, our 518 measures were sensitive to q, as desired and expected. 519 sequences, present at the same frequencies; as a result, they all have identical raw diversity 558 (for every value of q) despite their obvious quantitative and qualitative differences. In contrast, 559 functional diversity increases with the number of, and increasing difference between, 560 repertoires' constituent sequences. Node size denotes sequence frequency. Shades denote 561 different clonotypes. Comparing the third and fourth rows, note that even when two repertoires 562 have the same number and frequencies of unique sequences, the repertoire whose sequences 563 are more different from each other (random peptides) has the higher functional diversity. 564 Large symbols give an upper bound/worst-case scenario based on sampling meta-repertoires; 567 small symbols give results for a representative sample from DNA (circles) and mRNA 568 (triangles). First row: sample diversity is plotted as the effective number of sequences. For q=0, 569 functional diversity plateaus for TCRβ and IgH RNA and trends toward a plateau for IgH DNA at 570 the tested sample sizes; all three plateau for q=1; raw diversity does not plateau for either q=0 571 or q=1. Second row: discovery rate is the probability that the next sampled sequence will add to 572 the diversity. For example, for the IgH DNA representative sample, for q=0 raw diversity, at a 573 sample size of 1 million sequences there is still a probability of ~0.5 (a 50 percent chance) that 574 the next sequence to be sampled will be one that has not yet been seen and will therefore add 575 to the diversity. Third row: maximum error is the maximum fraction by which the diversity in the 576 sample can underestimate the diversity in the individual from whom the sample was taken. 577
Horizontal dashed lines indicate the threshold for two-fold error. For example, for the worst-case 578 scenario for TCRβ, q=0 functional diversity measured on a sample of 10,000 sequences will be 579 no more than a two-fold underestimate of diversity in the individual as a whole; in other words, 580 the sample value will be at least 50 percent of the overall value. 581 Matched pairs of symbols below the horizontal axis denote replicates. Note the difference in the 587 scale for functional diversity between IgH and TCRβ. Note also a general lack of correlation 588 between raw and functional species richness, except in (c). 589 functional species richness with age. Note that for each individual, the raw species richness is 625 ~10-fold higher than previously reported (Britanova 2014) , likely because the method we used 626 to correct for missing species (Recon) is more sensitive than the method used in the previous 627 report (Fisher). 628 distribution represents CDR3 sequences that bind a given target. Sequences are ordered by 630 their similarity to each other. (In reality, similarity is a multidimensional property that makes it purposes only.) The height at each sequence denotes the affinity with which it binds the target 633 (vertical axis; measured e.g. by K d ). Many more sequences bind the target at low affinity than at 634 high affinity, resulting in a "mountain-and-peak" appearance. This schematic is useful for 635 interpreting functional diversity as described in this study, and the raw diversity estimates based 636 on previous binding studies, as described in the Discussion. (Note that in this schematic, the 637 raw diversity as measured simply corresponds to the total number of sequences along, i.e. the 638 width of, the horizontal axis.) At high affinity, very few sequences bind a given target. At medium 639 affinity, more sequences bind, and can be binned into two small clusters, represented by the 640 small circles. At low affinity, many sequences bind, and can be binned into a single large 641 cluster, represented by the large circle. In (b)-(d), many targets are shown. Each color 642 corresponds to a different target; nearby targets are structurally similar. As in (a), each colored 643 area denotes the sequences that bind a given target, as a function of binding affinity (vertical 644 axis). Experiments usually detect the highest-affinity sequences: the peaks of the landscape 645 (above the horizontal dotted line). The narrower the peak when it crosses the experimental 646 threshold, the rarer specific sequences are, and the larger the number of targets that the 647 repertoire will be estimated to bind. (For example, if 100,000 sequences are shown across the 648 horizontal axis in each plot, and only one crosses the experimental threshold for a given target, 649 the frequency of sequences specific for that target is 1:100,000, and the conclusion will be that 650 there must be 100,000 such targets that the repertoire can bind. If 100 cross the experimental 651 threshold, the conclusion will be that the repertoire can bind only 1,000 targets.) Functional 652 diversity measures the overall contours of the landscape. Conceptually, this can be thought of 653 as measuring the number and size of the "mountains" at a lower affinity threshold (horizontal 654 solid lines). The differences in functional diversity between (b) memory IgH, (c) TCRβ, and (d) 655
naïve IgH correspond to different landscapes. The raw species richness of memory IgH and 656
TCRβ are comparable, represented here by the same width of all the plots. In addition, a similar 657 number of sequences per target cross the experimental threshold, so estimates of the total 658 number of targets that the repertoires can bind will also be comparable. However, less low-659 affinity overlap between the targets of the IgH sequences in (b) gives it higher functional species 660 richness than the TCRβ repertoire in (c): here, six functional clusters (white circles) vs. three. 661 (The sizes of the clusters are related to frequency-weighted functional diversity measures, i.e. 662 larger q.) The sequences in the naïve IgH repertoire in (d) have only low affinity for the six 663 colored targets, and many recognize more than one target (overlapping colored areas). Note the the average effect on K d of a single-amino-acid change in CDR3. If the effect were larger-or if 668 it were amplified by e.g. raising it to a power when building the similarity matrix-the threshold 669 would be higher, and vice versa. 670
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Box 1: Interpreting effective numbers
Consider two repertoires of 100 clones each. In the first repertoire, one clone is large and accounts for 91 percent of all cells (e.g. a leukemic clone); the other 99 clones are small and account for the remaining 9 percent. In the second repertoire, all 100 clones are equally common, each accounting for 1 percent of cells. The Shannon entropies of the two repertoires are 1.0 bit and 6.6 bits. Entropy is converted to an effective number-1 D-by exponentiation: the effective number of clones in the first repertoire is 2 1.0 =2, while in the second repertoire it is 2 6.6 =100. Thus per entropy, the first repertoire can be thought of as "effectively" consisting of just two clones: the 99 rare clones collectively count the same as the one large clone. In other words, the first repertoire has the same effective diversity as a repertoire that consists of just two clones that are equally common. The second repertoire already consists of clones that are equally common, so the effective number of clones in this repertoire, 2 6.6 =100, is the same as its species richness. Diversity with similarity is interpreted in a similar fashion: a repertoire with a q Ds of n species has the same effective diversity as a repertoire with n species that are equally common (as above), with the additional constraint that these species are now also completely unrelated to/ dissimilar from each other. 
